Medical Marijuana, Inc. portfolio company HempMeds® Brasil hosts CBD event at company’s San Diego home offices.
Medical Marijuana, Inc. subsidiary HempMeds® Brasil invited doctors from Brazil to an educational symposium on CBD, scientific research, and best practices for prescribing it. The event was hosted at Medical Marijuana, Inc.’s offices in downtown San Diego on Monday, April 30.
“HempMeds has a well-recognized global presence and a part of maintaining that presence is to connect influential leaders from different countries to continue to learn about cannabis and CBD,” said HempMeds® Brasil Vice President Caroline Heinz. “We’re happy that these doctors were able to travel all the way from Brazil for our event.”
The doctors in attendance toured the Medical Marijuana, Inc. home offices, meeting with Medical Marijuana, Inc. and HempMeds® Brasil executives and employees and seeing the hard work put in to ensuring that patients in Brazil have access to the CBD products prescribed by their doctors.
The group then gathered in our boardroom overlooking the beautiful San Diego Bay for presentations by Medical Marijuana, Inc. executives and noted clinical researchers that explored CBD and its many health and wellness benefits and detailed Medical Marijuana, Inc.’s efforts to spread access to CBD to patients throughout Latin America.
Speakers at the symposium featured executives from our company’s Latin American offices, including HempMeds® Brasil Vice President Caroline Heinz, HempMeds® Brasil Director of Medical Affairs Junior S. Gibelli, and HempMeds® Vice President of Latin America Raul Elizalde.
Raul Elizalde made national headlines last year when he was invited to speak before World Health Organization officials during a special committee meeting to decide whether or not CBD should be scheduled and regulated as a drug on the international level. Ultimately, the committee made the recommendation that CBD should not be classified as a restricted drug.
HempMeds® Brasil also invited noted clinical researchers Dr. Luiz Fernando Fonseca and Dr. Carlos G. Aguirre-Velazquez to share the results of their research focusing on the effects of CBD. Dr. Aguirre-Velazquez has worked with Medical Marijuana, Inc. products like THC-free RSHO-X™ in his CBD studies, exploring its potential effects for a range of medical indications.
Finally, Medical Marijuana, Inc. CEO and respected cannabinoid expert Dr. Stuart Titus spoke at the event, sharing his knowledge and experience regarding CBD. Dr. Titus regularly travels across the U.S. and around the world to speak at health and cannabis events.
“Having recently traveled to Brazil, it is nice to have these prominent medical professionals visit our home offices and provide them with personal interaction with some of our key international leaders,” said Medical Marijuana, Inc. CEO Dr. Stuart Titus. “We will continue to host home-and-home symposiums like this to help spread our knowledge on this amazing supplement and help increase global access.”
In 2014, HempMeds® Brasil became the first company to import a CBD-based product into Brazil for those suffering from various specific medical conditions. Real Scientific Hemp Oil™ is considered a prescription medication in the country, and purchases by approved patients in Brazil are now fully subsidized by the government.
HempMeds® Brasil works with thousands of families across Brazil in need of legal CBD products to help them navigate the necessary steps to access RSHO™ products. The company is also working hard to educate the medical community and regulatory agencies with events like the company’s recent symposium in San Diego and events in Brazil in an effort to make the process for obtaining cannabis products like RSHO™ easier.
If you are a patient or doctor in Brazil and would like to learn more about RSHO™, CBD oil, and the process to import CBD products here.
You can keep up to date with developments like this from the Medical Marijuana, Inc. family of companies by following our news feed.